Pharmaceuticals, Biotechnology and Life Sciences
The US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) for AstraZeneca’s Imfinzi (durvalumab) for the treatment of…
Frank Staud assumed the role of Executive Vice President Corporate Communications, Branding and Sponsoring on October 1. The 48-year old…
Plasticell, the biotechnology company specialising in stem cell screening and cell therapy development, has entered into a collaboration with GSK to…
The US Food and Drug Administration (FDA) has published the briefing documents ahead of the Advisory Committee meeting to discuss…
Fennec Pharmaceuticals revealed the data from its Phase 3 SIOPEL 6 study during the late breaker session on Saturday, October…
Silence Therapeutics has made a new appointment to its board of directors, in a significant moment in the transition of…
Omega, the medical diagnostics company focused on allergy, food intolerance and infectious disease, has signed a Supply Agreement with a…
Ablynx has expanded in the USA, with a subsidiary company, Ablynx Inc., as it has appointed Daniel Schneider as the General…
CPhI Worldwide – held in Frankfurt, October 24-26 and organised by UBM – announces the findings of part i of the 5th edition of the CPhI Annual…
Anavex Life Sciences has reported pharmacokinetic (PK) and pharmacodynamic (PD) data for ANAVEX2-73 from its positive Phase 2a study in…